Sexual dysfunction in women

Last reviewed: 26 Apr 2022
Last updated: 15 Sep 2020

Summary

Definition

History and exam

Key diagnostic factors

  • sexual symptoms leading to distress
  • absent/reduced sexual/erotic thoughts or fantasies
  • absent/reduced sexual excitement/pleasure during sexual activity
  • no subjective arousal from erotica
  • no awareness of genital response
  • no initiation of sexual activity
  • orgasm absent or of minimal intensity, or marked delay
  • spontaneous, intrusive, unpleasant genital congestion and feeling of impending orgasm
More key diagnostic factors

Other diagnostic factors

  • current stressors
  • absent/reduced interest in sexual activity
  • negative emotions during sex
  • minimal changes in temperature, muscle tension, heart rate during sex
  • vulvovaginal atrophy
  • loss of pubic hair
  • galactorrhoea
Other diagnostic factors

Risk factors

  • depression
  • antidepressant use
  • comorbid anxiety disorder
  • psychological aspects of cancer
  • breast cancer
  • gynaecological and other pelvic cancer
  • neurological disease
  • hyperprolactinaemia
  • radical hysterectomy (non-nerve-sparing)
  • cystectomy or proctectomy
  • mood, affect, and personality
  • relationship difficulties
  • attitudes
  • partner sexual dysfunction
  • reduced androgen activity
  • oestrogen deficiency
  • premature ovarian failure
  • post-partum
  • ageing
  • diabetes
  • renal failure
  • cardiovascular disease
  • polycystic ovarian syndrome (PCOS)
  • medicines
  • hypothalamic-pituitary disease
  • infertility
  • simple hysterectomy
  • lower urinary tract symptoms (LUTS)
  • socio-economic status
  • sexual abuse
More risk factors

Diagnostic investigations

1st investigations to order

  • FBC
  • serum glucose level
  • renal function
  • TFTs
  • serum prolactin level
More 1st investigations to order

Treatment algorithm

ONGOING

sexual interest/arousal disorder

female orgasmic disorder (FOD): lifelong

FOD: acquired (antidepressant-induced)

FOD: acquired (not antidepressant-induced)

Contributors

Authors

Rosemary Basson, MD, FRCP (UK)
Rosemary Basson

Clinical Professor

University of British Columbia

Departments of Psychiatry and Obstetrics/Gynecology

Vancouver

Canada

Disclosures

RB is an author or co-author of several references cited in this topic. RB's department has received research funding from the Canadian Institutes of Health Research (CIHR).

Acknowledgements

Dr Rosemary Basson would like to gratefully acknowledge Dr Lori Brotto, a previous contributor to this topic.

Disclosures

LB is an author or co-author of several references cited in this topic.

Peer reviewers

Milena Braga-Basaria, MD

Endocrinology Consultant

Johns Hopkins University

Division of Obstetrics and Gynecology

Baltimore

MD

Disclosures

MBB declares that she has no competing interests.

Philip Kell, MBBS, FRCOG, FRCP

Consultant Physician

Archway Sexual Health Clinic

Whittington Hospital

London

UK

Disclosures

PK has undertaken research studies for Boehringer Ingelheim.

  • Differentials

    • Sexual aversion
    • Marital discord
    More Differentials
  • Guidelines

    • The International Society for the Study of Women's Sexual Health process of care for the identification of sexual concerns and problems in women
    • Female sexual dysfunction
    More Guidelines
  • Patient leaflets

    Anxiety: what is it?

    Anxiety: what treatments work?

    More Patient leaflets
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer